Overview

Early Antenatal Support for Iron Deficiency Anemia

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Phase:
Phase 4
Details
Lead Sponsor:
Thomas Jefferson University
Collaborator:
Auerbach Hematology and Oncology
Treatments:
Ferrosoferric Oxide
Iron